Olaplex Holdings, Inc. (NASDAQ:OLPX – Get Free Report) Director John P. Bilbrey bought 25,128 shares of the stock in a transaction that occurred on Friday, November 15th. The stock was acquired at an average price of $1.76 per share, for a total transaction of $44,225.28. Following the acquisition, the director now directly owns 266,721 shares in the company, valued at $469,428.96. The trade was a 10.40 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.
Olaplex Stock Up 4.0 %
OLPX opened at $1.82 on Thursday. Olaplex Holdings, Inc. has a 12 month low of $1.19 and a 12 month high of $2.98. The company has a market cap of $1.21 billion, a PE ratio of 30.34 and a beta of 2.47. The company has a current ratio of 11.84, a quick ratio of 10.32 and a debt-to-equity ratio of 0.73. The company has a 50 day moving average of $2.10 and a 200 day moving average of $1.91.
Olaplex (NASDAQ:OLPX – Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.04 earnings per share for the quarter, meeting the consensus estimate of $0.04. The company had revenue of $119.10 million during the quarter, compared to analysts’ expectations of $126.51 million. Olaplex had a return on equity of 10.50% and a net margin of 9.78%. The firm’s quarterly revenue was down 3.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.05 earnings per share. On average, sell-side analysts expect that Olaplex Holdings, Inc. will post 0.11 EPS for the current year.
Hedge Funds Weigh In On Olaplex
Analysts Set New Price Targets
Several research firms have commented on OLPX. TD Cowen increased their price objective on shares of Olaplex from $1.80 to $2.00 and gave the company a “hold” rating in a research note on Wednesday, August 7th. Telsey Advisory Group restated a “market perform” rating and issued a $3.00 price objective on shares of Olaplex in a research note on Thursday, November 7th. Finally, Barclays lowered their target price on Olaplex from $2.00 to $1.50 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $2.30.
Get Our Latest Report on Olaplex
About Olaplex
Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.
Further Reading
- Five stocks we like better than Olaplex
- How to Evaluate a Stock Before BuyingÂ
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- 3 Healthcare Dividend Stocks to Buy
- Williams-Sonoma Stock: Buy It and Never Let It Go
- What is the FTSE 100 index?
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.